25th Feb 2026 ADACCESS trial results comparing GP2017 (adalimumab biosimilar) and reference adalimumab treatments for plaque psoriasis: a plain language summary
17th Mar 2025 A plain language summary of the combined safety findings of adalimumab-adbm from the VOLTAIRE clinical trials in individuals with rheumatoid arthritis, Crohn’s disease, and chronic plaque psoriasis
20th Sep 2022 Plain language summary of the VOLTAIRE-RA study in patients with moderate-to-severe rheumatoid arthritis
